Tenax Therapeutics Inc. (NASDAQ: TENX) stock fell -0.63% on Monday to $2.57 against a previous-day closing price of $2.59. With 0.17 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.35 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.6400 whereas the lowest price it dropped to was $2.4708. The 52-week range on TENX shows that it touched its highest point at $17.00 and its lowest point at $1.60 during that stretch. It currently has a 1-year price target of $90.00. Beta for the stock currently stands at 2.15.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TENX was up-trending over the past week, with a rise of 9.05%, but this was down by -5.73% over a month. Three-month performance dropped to -23.40% while six-month performance fell -51.37%. The stock lost -81.74% in the past year, while it has gained 15.51% so far this year. A look at the trailing 12-month EPS for TENX yields -0.48 with Next year EPS estimates of -2.60. For the next quarter, that number is -1.70. This implies an EPS growth rate of -20.70% for this year and 67.50% for next year.
Float and Shares Shorts:
At present, 26.33 million TENX shares are outstanding with a float of 1.83 million shares on hand for trading. On Dec 29, 2022, short shares totaled 33140.0, which was 1.48% higher than short shares on Nov 29, 2022. In addition to Mr. Christopher T. Giordano as the firm’s CEO, Pres & Director, Mr. Eliot M. Lurier CPA serves as its Interim Chief Financial Officer.
Through their ownership of 15.89% of TENX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 0.00% of TENX, in contrast to — held by mutual funds. Shares owned by individuals account for –. With a 0.00% stake in TENX, the iShares Core S&P Total US Stock M is the largest stakeholder. A total of 31 shares are owned by the mutual fund manager.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Sep 29, 2022, TENX reported revenue of $0.00 and operating income of -$2.86M. The EBITDA in the recently reported quarter was -$2.83M and diluted EPS was -$2.20.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TENX since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With TENX analysts setting a high price target of $100.00 and a low target of $100.00, the average target price over the next 12 months is $100.00. Based on these targets, TENX could surge 3791.05% to reach the target high and rise by 3791.05% to reach the target low. Reaching the average price target will result in a growth of 3791.05% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. TENX will report FY 2022 earnings on 02/28/2024. Analysts have provided yearly estimates in a range of -$8.00 being high and -$8.00 being low. For TENX, this leads to a yearly average estimate of -$8.00. The surprise factor in the prior quarter was -$0.40. Based on analyst estimates, the high estimate for the next quarter is -$1.60 and the low estimate is -$1.80. The average estimate for the next quarter is thus -$1.70.
Summary of Insider Activity:
Insiders traded TENX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 2 while that of sell transactions has risen to 2 over the past year. The total number of shares bought during that period was 2,477,456 while 2,477,456 shares were sold.